Fny Investment Advisers, LLC Cv Sciences, Inc. Transaction History

Fny Investment Advisers, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 09, 2020	SELL	$0.47 - $0.79 $7,919 - $13,311	-16,850 Closed	0 $0
Q2 2020 Jul 10, 2020	BUY	$0.37 - $1.18 $5,309 - $16,933	14,350 Added 574.0%	16,850 $10,000
Q1 2020 Apr 09, 2020	BUY	$0.29 - $1.26 $362 - $1,575	1,250 Added 100.0%	2,500 $1,000
Q4 2019 Jan 10, 2020	SELL	$0.86 - $2.58 $26,015 - $78,045	-30,250 Reduced 96.03%	1,250 $1,000
Q3 2019 Oct 25, 2019	SELL	$1.72 - $4.24 $80,840 - $199,280	-47,000 Reduced 59.87%	31,500 $54,000

Q2 2019 Jul 24, 2019	SELL	$3.93 - $6.08 $50,524 - $78,164	-12,856 Reduced 14.07%	78,500 $319,000
Q1 2019 Apr 17, 2019	BUY	$4.18 - $6.26 $381,868 - $571,888	91,356 New	91,356 $540,000

Ticker CVSI
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 147,794,000
Market Cap $7.39M
Description
CV Sciences, Inc. operates as a life science company in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The Consumer Products segment develops, manufactures, and markets plant-based dietary supplements and hemp-based cannabidiol (CBD) products under the PlusCBD, ProCBD, HappyLane, CV Acute, CV Defense,...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.